|
|
salirasib A salicylic acid derivative with potential antineoplastic activity. Salirasib dislodges all Ras isoforms from their membrane-anchoring sites, thereby preventing activation of RAS signaling cascades that mediated cell proliferation, differentiation, and senescence. RAS signaling is believed to be abnormally activated in one-third of human cancers, including cancers of the pancreas, colon, lung and breast.
Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
Chemical structure name: | | s-trans, trans-farnesylthiosalicylic acid | | |
|
|